Schedule 13D ownership disclosure

INOTEK PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 45780V102

Event date: 2017-10-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-004092
Form type
SC 13D/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Oct 26, 2017
Reporting period
Oct 24, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub